Screening for NAFLD in Flanders

Not Applicable

Recruiting

• Conditions: Non-Alcoholic Fatty Liver Disease

• Registration Number: NCT04647409
• Lead Sponsor: Hasselt University

Brief Summary

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-26
• Study First Submitted: 2020-11-26
• Study First Submitted QC: 2020-11-26
• Study First Posted: 2020-11-30
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-28
• Last Update Posted: 2024-02-29
• Primary Completion: 2024-12-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• 18 years or older,
• able to understand Dutch,
• able to understand the informed consent

Exclusion Criteria

• secondary causes of steatosis
• excessive alcohol abuse

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
CLDQ-NAFLD	baseline	The determination of the prevalence of NAFLD in a general population in Flanders, Belgium by using A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
36-Item Short Form Survey (SF-36)	baseline	SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.

Trial Locations

Locations (1)

Hasselt University; 🇧🇪 Hasselt, Belgium